Advances in Cancer Immunotherapy
Cancer immunotherapy utilizes the immune system to identify and target cancer cells. Over the past decades, researchers have advanced these treatments by (1) uncovering how tumors evade the immune system and (2) developing techniques to trigger an anti-tumor immune response and block tumor immune es...
Saved in:
| 格式: | Online |
|---|---|
| 語言: | 英语 |
| 出版: |
IntechOpen
2024
|
| 主題: | |
| 在線閱讀: | ONIX_20241025_9780854663798_40 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
| _version_ | 1869515435600248832 |
|---|---|
| collection | Directory of Open Access Books |
| description | Cancer immunotherapy utilizes the immune system to identify and target cancer cells. Over the past decades, researchers have advanced these treatments by (1) uncovering how tumors evade the immune system and (2) developing techniques to trigger an anti-tumor immune response and block tumor immune escape. These immunotherapies can be administered alone or in combination with other treatments, leading to an improved survival rate and quality of life for cancer patients. Indeed, several immunotherapies have received approval from the United States Food and Drug Administration (FDA) for the treatment of various cancers. For instance, blocking PD-1/PD-L1 has increased the five-year survival rate for patients with advanced non-small-cell lung cancer. However, the effectiveness of current immunotherapies varies significantly among patients, and they can cause severe side effects. Although there is still a need for improvement, cancer immunotherapy is regarded as a promising therapeutic modality. This book focuses on the preclinical development and evolving clinical landscape of cancer immunotherapy, encouraging synthetic organic/medicinal chemists, immunologists, and biologists to develop new, safe, and affordable treatments. |
| format | Online |
| id | doab-20.500.12854ir-146497 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | IntechOpen |
| publisherStr | IntechOpen |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1464972024-10-25T10:48:12Z Advances in Cancer Immunotherapy Mukai, Shin Oncology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Cancer immunotherapy utilizes the immune system to identify and target cancer cells. Over the past decades, researchers have advanced these treatments by (1) uncovering how tumors evade the immune system and (2) developing techniques to trigger an anti-tumor immune response and block tumor immune escape. These immunotherapies can be administered alone or in combination with other treatments, leading to an improved survival rate and quality of life for cancer patients. Indeed, several immunotherapies have received approval from the United States Food and Drug Administration (FDA) for the treatment of various cancers. For instance, blocking PD-1/PD-L1 has increased the five-year survival rate for patients with advanced non-small-cell lung cancer. However, the effectiveness of current immunotherapies varies significantly among patients, and they can cause severe side effects. Although there is still a need for improvement, cancer immunotherapy is regarded as a promising therapeutic modality. This book focuses on the preclinical development and evolving clinical landscape of cancer immunotherapy, encouraging synthetic organic/medicinal chemists, immunologists, and biologists to develop new, safe, and affordable treatments. 2024-10-25T10:47:57Z 2024-10-25T10:47:57Z 2024 book ONIX_20241025_9780854663798_40 9780854663798 9780854663804 9780854663811 https://directory.doabooks.org/handle/20.500.12854/146497 eng image/jpeg n/a https://www.intechopen.com/books/1003462 https://intech-files.s3.amazonaws.com/a043Y000010Jz7lQAC/0015366_Authors_Book%20%282024-09-26%2009%3A35%3A53%29.pdf IntechOpen IntechOpen 10.5772/intechopen.1001680 10.5772/intechopen.1001680 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9780854663798 9780854663804 9780854663811 IntechOpen 152 open access |
| spellingShingle | Oncology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Advances in Cancer Immunotherapy |
| title | Advances in Cancer Immunotherapy |
| title_full | Advances in Cancer Immunotherapy |
| title_fullStr | Advances in Cancer Immunotherapy |
| title_full_unstemmed | Advances in Cancer Immunotherapy |
| title_short | Advances in Cancer Immunotherapy |
| title_sort | advances in cancer immunotherapy |
| topic | Oncology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | Oncology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20241025_9780854663798_40 |